{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:12:46Z","timestamp":1770498766318,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12325-008-0028-8","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T01:51:18Z","timestamp":1205459478000},"page":"266-273","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of GnRH agonists and antagonists in normoresponder IVF\/ICSI in Turkish female patients"],"prefix":"10.1007","volume":"25","author":[{"given":"Ozlem","family":"Moraloglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevtap","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Karayal\u00e7in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beril","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicel","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00e7a","family":"I\u015fik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ugur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,14]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM199808273390901","volume":"339","author":"A. Templeton","year":"1998","unstructured":"Templeton A, Morris JK. Reducing the risk of multiple births by transfer of the embryos after in vitro fertilization. N Engl J Med. 1998;339:573\u2013577.","journal-title":"N Engl J Med"},{"key":"28_CR2","first-page":"14","volume":"11","author":"C. Albano","year":"1996","unstructured":"Albano C, Smitz J, Camus M, et al. Hormonal profile during the follicular phase in cycles stimulated with recombination of human menopausal gonadotropin and gonadotropin-releasing hormone antagonist (Cetrorelix). Hum Reprod. 1996;11:14\u201318.","journal-title":"Hum Reprod"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/jm00160a008","volume":"29","author":"J.E. Rivier","year":"1986","unstructured":"Rivier JE, Porter J, Rivier CL. New effective GnRH antagonists with minimal potency for histamine release in vitro. J Med Chem. 1986;29:1846\u20131851.","journal-title":"J Med Chem"},{"key":"28_CR4","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006;(3):CD001750.","DOI":"10.1002\/14651858.CD001750.pub2"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","volume":"88","author":"F.P. Hohmann","year":"2003","unstructured":"Hohmann FP, Macklon NS, Fauser BCJM. A randomized comparison of two ovarian stimulation protocols with GnRH antagonist cotreatment for IVF commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRHa protocol. J Clin Endocrinol Metab. 2003;88:166\u2013173.","journal-title":"J Clin Endocrinol Metab"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(02)04696-4","volume":"79","author":"E.M. Kolibianakis","year":"2003","unstructured":"Kolibianakis EM, Albano C, Kahn J, Camus M. Exposure to high levels of luteinizing hormone and estradiol in early follicular phase of GnRH antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril. 2003;79:603\u2013607.","journal-title":"Fertil Steril"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/17.11.2842","volume":"17","author":"M. Ludwig","year":"2002","unstructured":"Ludwig M, Katalinic A, Banz C. Tailoring the GnRH antagonist cetrorelix acetate to individual patient\u2019s needs in ovarian stimulation for IVF: results of prospective, randomized study. Hum Reprod. 2002;17:2842\u20132845.","journal-title":"Hum Reprod"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-0412.2003.820108.x","volume":"82","author":"R.T. Mansour","year":"2003","unstructured":"Mansour RT, Aboulghar MA, Serour GI. The use of clomiphene citrate\/human menopausal gonodotropins in conjunction with GnRH antagonist in an IVF\/ICSI program is not a cost effective protocol. Acta Obstet Gynecol Scand. 2003;82:48\u201352.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humrep\/deg021","volume":"18","author":"J.-L. Hwang","year":"2003","unstructured":"Hwang J-L, Huang L-W, Hsieh B-C. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod. 2003;18:45\u201349.","journal-title":"Hum Reprod"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0301-2115(01)00580-2","volume":"102","author":"J.C.B. Gadillo Del","year":"2002","unstructured":"Del Gadillo JCB, Siebzehnr\u00fcbl E, Dittrich R. Comparison of GnRH agonists and antagonists in unselected IVF\/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol. 2002;102:179\u2013183.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/humrep\/16.11.2258","volume":"16","author":"G. Ragni","year":"2001","unstructured":"Ragni G, Vegetti W, Baroni E. Comparison of luteal phase profile in gonadotropin stimulated cycles with or without a gonadotropin-releasing hormone antagonist. Hum Reprod. 2001;16:2258\u20132262.","journal-title":"Hum Reprod"},{"issue":"5suppl","key":"28_CR12","first-page":"51","volume":"86","author":"Practice Committee of the Society for Assisted Reproductive Technology; Practice Committee of the American Society for Reproductive Medicine.","year":"2006","unstructured":"Practice Committee of the Society for Assisted Reproductive Technology; Practice Committee of the American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Fertil Steril. 2006;86(5 suppl):51\u201352.","journal-title":"Fertil Steril"},{"issue":"suppl1","key":"28_CR13","first-page":"114","volume":"18","author":"L. Londra","year":"2003","unstructured":"Londra L, Inza R, Lombardi E, Marconi G, Young E, Kenny A. GnRh antagonist versus GnRh agonist in good prognosis IVF patients. Hum Reprod. 2003;18(suppl 1):114.","journal-title":"Hum Reprod"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"G. Borm","year":"2000","unstructured":"Borm G, Mannaerts B, for the European Orgalutran Study Group. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod. 2000;15:1490\u20131498.","journal-title":"Hum Reprod"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","volume":"73","author":"F. Olivennes","year":"2000","unstructured":"Olivennes F, Belaisch-Allart J, Emperaire JC. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril. 2000;73:314\u2013320.","journal-title":"Fertil Steril"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","volume":"75","author":"M. Fluker","year":"2001","unstructured":"Fluker M, Grifo J, Leader A, Levy M, for the North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2001;75:38\u201345.","journal-title":"Fertil Steril"},{"key":"28_CR17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","volume":"16","author":"The EuropeanMiddle East Orgalutran Study Group.","year":"2001","unstructured":"The European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod. 2001;16:644\u2013651.","journal-title":"Hum Reprod"},{"key":"28_CR18","first-page":"84","volume":"50","author":"M. Bahceci","year":"2005","unstructured":"Bahceci M, Ulug U, Ben-Shlomo I. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med. 2005;50:84\u201390.","journal-title":"J Reprod Med"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.fertnstert.2004.11.060","volume":"83","author":"K. Zikopoulos","year":"2005","unstructured":"Zikopoulos K, Kapanis A, Adonakis G. A prospective randomized study comparing gonadotropin releasing hormone agonists or gonadotropin releasing hormone antagonists in couples with unexplained infertility and\/or mild oligozoospermia Fertil Steril. 2005;83:1354\u20131362.","journal-title":"Fertil Steril"},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ogc.2004.03.004","volume":"31","author":"M.L. Check","year":"2004","unstructured":"Check ML, Check JH, Choel JK. Effect of antagonists versus agonists on in vitro fertilization outcome. Clin Exp Obstet Gynecol. 2004;31:257\u2013259.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"28_CR21","first-page":"i103","volume":"19","author":"F. Causio","year":"2004","unstructured":"Causio F, Sarcina E, Leonetti T. GnRH agonist versus GnRH antagonist in an IVF programme: luteal phase hormonal characteristics. Hum Reprod. 2004;19:i103.","journal-title":"Hum Reprod"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","volume":"15","author":"C. Albano","year":"2000","unstructured":"Albano C, Felberbaum RE, Smitz J. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormonereleasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod. 2000;15:526\u2013531.","journal-title":"Hum Reprod"},{"key":"28_CR23","first-page":"49","volume":"10","author":"A. Badrawy","year":"2005","unstructured":"Badrawy A, Al-Inany H, Hussein M, Zaki S, Ramzy AM. Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis. Middle East Fertil Soc J. 2005;10:49\u201354.","journal-title":"Middle East Fertil Soc J"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2004.12.037","volume":"83","author":"T.H. Lee","year":"2005","unstructured":"Lee TH, Wu MY, Chen HF, Chen MJ, Ho HN, Yang YS. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration. Fertil Steril. 2005;83:1700\u20131707.","journal-title":"Fertil Steril"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0028-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0028-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:50Z","timestamp":1559447750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0028-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0028-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}